AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 94 filers reported holding AVROBIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,187 | -98.4% | 10,082 | -98.6% | 0.00% | – |
| Q3 2022 | $454,000 | +233.8% | 706,838 | +376.2% | 0.00% | – |
| Q2 2022 | $136,000 | -62.1% | 148,446 | -45.4% | 0.00% | – |
| Q1 2022 | $359,000 | -93.3% | 271,749 | -80.3% | 0.00% | -100.0% |
| Q4 2021 | $5,319,000 | +120.6% | 1,381,758 | +219.7% | 0.00% | 0.0% |
| Q3 2021 | $2,411,000 | -37.2% | 432,138 | +0.0% | 0.00% | 0.0% |
| Q2 2021 | $3,841,000 | -10.1% | 432,105 | +28.3% | 0.00% | 0.0% |
| Q1 2021 | $4,273,000 | -36.8% | 336,739 | -30.5% | 0.00% | -50.0% |
| Q4 2020 | $6,758,000 | +14.4% | 484,797 | +6.9% | 0.00% | 0.0% |
| Q3 2020 | $5,906,000 | -3.1% | 453,574 | +29.9% | 0.00% | 0.0% |
| Q2 2020 | $6,095,000 | +329.8% | 349,269 | +283.4% | 0.00% | – |
| Q1 2020 | $1,418,000 | -16.8% | 91,108 | +7.6% | 0.00% | – |
| Q4 2019 | $1,704,000 | +32.6% | 84,652 | -7.0% | 0.00% | – |
| Q3 2019 | $1,285,000 | +3.8% | 91,060 | +19.6% | 0.00% | – |
| Q2 2019 | $1,238,000 | -28.1% | 76,153 | -2.5% | 0.00% | -100.0% |
| Q1 2019 | $1,723,000 | +378.6% | 78,141 | +261.6% | 0.00% | – |
| Q4 2018 | $360,000 | -76.0% | 21,609 | -58.8% | 0.00% | – |
| Q2 2018 | $1,499,000 | – | 52,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |